Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome
- 25 May 2006
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 65 (1), 64-70
- https://doi.org/10.1111/j.1365-2265.2006.02547.x
Abstract
Objective There are close phenotypic similarities between cortisone reductase deficiency (CRD), a rare abnormality of cortisone metabolism, and polycystic ovary syndrome (PCOS). As there is evidence that CRD results from digenic mutations involving the genes encoding 11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) and hexose-6-phosphate dehydrogenase (H6PD), we sought to establish whether CRD-associated variants in these genes, individually or in combination, influence susceptibility to PCOS. Design Case-control, family-based association and quantitative-trait analyses. Patients A UK case sample comprising 256 nuclear families ascertained from a PCOS offspring and 213 singleton PCOS cases plus 549 control subjects. Measurements All subjects were genotyped for CRD-related variants in HSD11B1 (rs12086634) and H6PD (rs6688832). Testosterone was measured with an in-house radioimmunoassay using ether extraction and dextran-coated charcoal separation. Results Case-control analyses revealed no differences in genotype distribution between PCOS and controls for rs12086634 or rs6688832 (both P = 0·84). Three per cent of cases and 2·4% of controls had genotype combinations (three or more variant alleles at the two sites) considered characteristic of CRD (P = 0·73). There were no departures from expectation in the family-based association studies, and no significant associations between genotypes (individually or in combination) and BMI, WHR or testosterone. Conclusions The variants in HSD11B1 and H6PD typed, though implicated in causation of CRD, do not influence susceptibility to PCOS. It seems likely that additional variants within these genes are required for the development of CRD.Keywords
This publication has 29 references indexed in Scilit:
- Hexose‐6‐phosphate dehydrogenase determines the reaction direction of 11β‐hydroxysteroid dehydrogenase type 1 as an oxoreductaseFEBS Letters, 2004
- Genotype‐based association test for general pedigrees: The genotype‐PDTGenetic Epidemiology, 2003
- 11β-Hydroxysteroid Dehydrogenase Type 1 Deficiency (‘Apparent Cortisone Reductase Deficiency’) in a 6-Year-Old BoyHormone Research in Paediatrics, 2003
- A Test for Linkage and Association in General Pedigrees: The Pedigree Disequilibrium TestAmerican Journal of Human Genetics, 2000
- Failure of Cortisone Acetate Treatment in Congenital Adrenal Hyperplasia because of Defective 11 -Hydroxysteroid Dehydrogenase Reductase ActivityJournal of Clinical Endocrinology & Metabolism, 1999
- An extended transmission/disequilibrium test (TDT) for multi‐allele marker lociAnnals of Human Genetics, 1995
- Defects in the HSD11 gene encoding 11 beta-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11- oxoreductase deficiencyJournal of Clinical Endocrinology & Metabolism, 1993
- Safety of pertussis vaccineThe Lancet, 1990
- Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.BMJ, 1986
- A new defect in the peripheral conversion of cortisone to cortisolJournal of Steroid Biochemistry, 1985